Submitted by Anonymous (not verified) on 12 August 2025 - 14:54
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Opinion under re-examination
Source:
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Opinion under re-examination